CO21 Matching Adjusted Indirect Comparison (MAIC) of Selpercatinib Vs Cabozantinib in RET Mutation-Positive Advanced Medullary Thyroid Cancer (MTC)

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.094
https://www.valueinhealthjournal.com/article/S1098-3015(23)03224-2/fulltext
Section Title :
Section Order : 10412
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03224-2&doi=10.1016/j.jval.2023.09.094
HEOR Topics :
Tags :
Regions :